Molecular Detection of Lymph Node Metastases in Lung Cancer Patients Using the One-Step Nucleic Acid Amplification Method:Clinical Significance and Prognostic Value
暂无分享,去创建一个
A. Concha | F. Picchi | Ricardo Fernández-Prado | L. Estévez-Pérez | María Teresa Hermida-Romero | Mercedes de la Torre-Bravos | B. O. Alen
[1] A. Berjón,et al. One-Step Nucleic Acid Amplification (OSNA) of Sentinel Lymph Node in Early-Stage Endometrial Cancer: Spanish Multicenter Study (ENDO-OSNA) , 2021, Cancers.
[2] R. Henke,et al. Evaluation of Fast Molecular Detection of Lymph Node Metastases in Prostate Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA) , 2021, Cancers.
[3] S. Landolfi,et al. Lymph Node Tumor Burden Correlates With Tumor Budding and Poorly Differentiated Clusters: A New Prognostic Factor in Colorectal Carcinoma? , 2021, Clinical and translational gastroenterology.
[4] V. Peg,et al. Predictive and prognostic value of total tumor load in sentinel lymph nodes in breast cancer patients after neoadjuvant treatment using one-step nucleic acid amplification: the NEOVATTL study , 2021, Clinical and Translational Oncology.
[5] S. Kehoe,et al. The evolving role of one-step nucleic acid amplification (OSNA) for the intra-operative detection of lymph node metastases: A diagnostic accuracy meta-analysis. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[6] O. Topolcan,et al. Prognostic Significance of Lymph Node Examination by the OSNA Method in Lung Cancer Patients—Comparison with the Standard Histopathological Procedure , 2020, Cells.
[7] K. Yasufuku,et al. Sentinel lymph node biopsy for lung cancer , 2020, General Thoracic and Cardiovascular Surgery.
[8] Ricardo Fernández Prado,et al. Detection of lymph node metastasis in lung cancer patients using a one-step nucleic acid amplification assay: a single-centre prospective study , 2019, Journal of Translational Medicine.
[9] Y. She,et al. Lymph Node Micrometastasis Prognosticates Survival for Patients with Stage 1 Bronchogenic Adenocarcinoma , 2018, Annals of Surgical Oncology.
[10] Liping Jiang,et al. The diagnostic value of one step nucleic acid amplification (OSNA) in differentiating lymph node metastasis of tumors: A systematic review and meta-analysis. , 2018, International journal of surgery.
[11] O. Topolcan,et al. A more sensitive detection of micrometastases of NSCLC in lymph nodes using the one‐step nucleic acid amplification (OSNA) method , 2018, Journal of surgical oncology.
[12] J. Pyo,et al. Prognostic roles of lymph node micrometastasis in non-small cell lung cancer. , 2017, Pathology, research and practice.
[13] L. Chirieac,et al. Long‐term outcomes after near‐infrared sentinel lymph node mapping in non–small cell lung cancer , 2017, The Journal of thoracic and cardiovascular surgery.
[14] Jeffrey E Gershenwald,et al. Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.
[15] M. Pocard,et al. Molecular analysis of sentinel lymph node in colon carcinomas by one-step nucleic acid amplification (OSNA) reduces time to adjuvant chemotherapy interval. , 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[16] V. Rusch,et al. Lung cancer — major changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.
[17] F. Balaguer,et al. Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma , 2017, Journal of Translational Medicine.
[18] H. Asamura,et al. The novel one-step nucleic acid amplification (OSNA) assay for the diagnosis of lymph node metastasis in patients with non-small cell lung cancer (NSCLC): Results of a multicenter prospective study. , 2016, Lung cancer.
[19] N. Tomita,et al. OSNA-Assisted Molecular Staging in Colorectal Cancer: A Prospective Multicenter Trial in Japan , 2016, Annals of Surgical Oncology.
[20] M. Kris,et al. Adjuvant chemotherapy for resected early-stage non-small cell lung cancer. , 2015, The Cochrane database of systematic reviews.
[21] W. Travis. WHO classification of tumours of the lung, pleura, thymus and heart , 2015 .
[22] S. Vieni,et al. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma. , 2015, Annali italiani di chirurgia.
[23] B. Esterni,et al. Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: a French sentinel node multicenter cohort study. , 2014, Breast.
[24] D. Lips,et al. The Diagnostic Value of One-Step Nucleic acid Amplification (OSNA) for Sentinel Lymph Nodes in Colon Cancer Patients , 2014, Annals of Surgical Oncology.
[25] C. Buskens,et al. The prognostic value of micrometastases and isolated tumour cells in histologically negative lymph nodes of patients with colorectal cancer: a systematic review and meta-analysis. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[26] H. Tsuda,et al. Multicenter study evaluating the clinical performance of the OSNA assay for the molecular detection of lymph node metastases in gastric cancer patients , 2013, Gastric Cancer.
[27] A. Jemal,et al. Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.
[28] E. Morii,et al. An accurate and rapid detection of lymph node metastasis in non-small cell lung cancer patients based on one-step nucleic acid amplification assay. , 2012, Lung cancer.
[29] T. Kinoshita,et al. Routine clinical use of the one‐step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients , 2012, Cancer.
[30] N. Demartines,et al. Molecular Investigation of Lymph Nodes in Colon Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA) , 2012, Cancer.
[31] F. Akiyama,et al. Accurate staging of axillary lymph nodes from breast cancer patients using a novel molecular method , 2011, British Journal of Cancer.
[32] I. V. D. van der Ploeg,et al. Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] Donald L. Weaver,et al. Effect of occult metastases on survival in node-negative breast cancer. , 2011, The New England journal of medicine.
[34] I. B. Borel Rinkes,et al. Prognostic Value of Lymph Node Micrometastases in Breast Cancer: A Multicenter Cohort Study , 2010, Annals of Surgical Oncology.
[35] H. Tsuda,et al. Molecular Detection of Lymph Node Metastases in Breast Cancer Patients: Results of a Multicenter Trial Using the One-Step Nucleic Acid Amplification Assay , 2009, Clinical Cancer Research.
[36] S. Cristina,et al. Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[37] H. Tsuda,et al. One-step Nucleic Acid Amplification for Intraoperative Detection of Lymph Node Metastasis in Breast Cancer Patients , 2007, Clinical Cancer Research.
[38] T. Oyama,et al. Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.